LYC 0075 Share Price
RM0.30
52 Weeks Range : 0.16 - 0.31
1.1/10 (Expert Score)
Product is rated as #180 in category Ace Market CONS:
- Making Huge Loss
- No Dividend Declared
- Very Low Price-to-Tangible
- Company in Debt
- Very High Gearing
klse: LYC Healthcare Bhd
Corporate Information
Board : Ace
Shariah : Shariah Compliant
Sector : Hospital or Centre Electrical Product Computer Hardware and Software E-commerce Service
Address: Level 2, Podium Block, Plaza VADS, 1, Jalan Tun Mohd Fuad, Taman Tun Dr Ismail, 60000, Kuala Lumpur
Contact: +603-77339222
Website: https://www.lychealth.com/
Corporate Background
LYC Healthcare Berhad provides health care services. The Company offers mother and child centre, child specialist, family clinic, and senior living services such as recovery and wellness therapy, postnatal yoga, specialized confinement meals, nursery care, and other related services. LYC Healthcare serves customers in Malaysia.
Specification: LYC 0075
|
Result
Quarter Report History
| Date | Revenue,k | PBT,k | Net Profit,k |
|---|---|---|---|
| 29/11/22 | 22,009 | -2,561 | -4,409 |
| 25/08/22 | 21,119 | -2,038 | -4,471 |
| 31/05/22 | 19,565 | 3,134 | 251 |
| 28/02/22 | 21,181 | -1,078 | -3,337 |
| 25/11/21 | 12,147 | -1,489 | -2,976 |
| 26/08/21 | 11,703 | -1,647 | -3,025 |
| 27/05/21 | 13,079 | -973 | -1,671 |
| 25/02/21 | 6,526 | -4,324 | -4,559 |
| 25/11/20 | 3,876 | -3,017 | -2,863 |
| 28/08/20 | 2,628 | -2,708 | -2,576 |
| 25/06/20 | 3,098 | -4,309 | -4,050 |
| 28/02/20 | 3,597 | -2,207 | -2,056 |
Fundamental
Fundamental Analysis
| Last 4 Quarter Revenue (RM’000) | 83,874 |
|---|---|
| Last 4 Quarter Net Profit (RM’000) | -6,593 |
| Last 4 Quarter EPS (sen) | -2.49 |
| Last 4 Quarter PER | – |
| Last 4 Quarter Dividend (sen) | – |
| Last 4 Quarter Dividend Yield (%) | – |
| Net Tangible Assets (RM) | 0.06 |
| Goodwill (RM) | 128,260 |
| Cash (RM’000) | 35,690 |
| Debt (RM’000) | 131,430 |
| Total Debt (RM’000) | 150,190 |
| Net Assets (RM’000) | 41,570 |
| Current Ratio | 2.54 |
| Quick Ratio | 2.22 |
| Cash Ratio | 1.07 |
Technical
Technical Analysis
| MACD (26 vs 12) | 0.009 |
|---|---|
| Exponential Moving Average 5 | 0.243 |
| Exponential Moving Average 20 | 0.217 |
| Exponential Moving Average 90 | 0.202 |
| Relative Strength Index 14 | 0.76 |
| Stochastic %D 3 | 0.58 |
| Stochastic %K 14 | 1.00 |
8 reviews for LYC 0075
Show all Most Helpful Highest Rating Lowest Rating
Add a review
Over Optimistic
Top rated products
-
SUNVIEW 0262 ★★★★★RM0.73 - INFOTEC 0253 ★★★★★RM0.92
- PETRONM 3042 ★★★★★
RM9.15RM4.58 - CMSB 2852 ★★★★★
RM2.19RM1.25 - MEDIAC 5090 ★★★★★
RM0.19RM0.18
BURSA MALAYSIA –
The loss before tax was RM2.56 million compared to RM2.04 million recorded in the preceding quarter. The higher losses before tax in the current quarter was mainly due to the higher operating expenses incurred in relation to professional fees for the listing exercise.
BURSA MALAYSIA –
A loss before tax of RM2.04 million compared to a profit before tax of RM3.00 million in the preceding quarter was mainly due to the absence of a one-off gain of RM4.70 million on the redemption of RPS which was issued to the vendor of T&T, and the capitalization of transaction costs of RM0.46 million on shares issued in the preceding quarter.
BURSA MALAYSIA –
The financial performance had turned from a loss before tax for the current quarter of RM1.08 million to a profit before tax of RM3.13 million. The decrease in revenue translated to a lower gross margin for the period. However, the overall decrease in revenues was partly offset by a one of gain on the redemption of RPS which was issued to vendor of T&T of RM4.70 million
BURSA MALAYSIA –
The increase in revenue has translated to a higher gross margin after the consolidation of Aqurate, which was acquired in September 2021. As a result, the loss before tax for the current quarter declined to RM1.08 million from RM1.49 million, representing an improvement of 28% or RM0.41 million.
BURSA MALAYSIA –
The Group recorded revenue of RM2.62 million, representing a decrease of RM0.47 million or 15% as compared to preceding quarter of RM3.09 million. The decrease in revenue was mainly de to the Healthcare and other segment, which recorded a decrease by RM0.29 million and RM0.30 million respectively. The loss before tax in the current quarter of RM2.70 million reported was 37% lower in comparison to the loss before tax of RM4.30 million in the preceding quarter.
REMUNERATION STUDY –
In Financial Year End 2020, the directors’ remuneration was 1.52 million. It was slightly high compared to average in listed companies, considering the employees’ remuneration of 7.6 million and auditor’s remuneration of 130 thousands
BURSA MALAYSIA –
The Group recorded revenue of RM3.09 million, representing a decrease of RM0.50 million or 14% as compared to its immediate preceding quarter of RM3.59 million. The overall decrease in revenue is mainly attributed to Healthcare segment and Computing and Electronic services which recorded a decrease by RM0.27 million and RM0.23 million respectively. Lower revenue recorded is mainly due to Movement Control Order (“MCO”).
Investing Malaysia –
Average investing volume for LYC Healthcare Bhd in the past three months in stock market was 480.2k lots
Investing Malaysia –
LYC gets a score of 1.16 in our equity and assets quality test based on current share price of RM0.255
Investing Malaysia –
LYC Healthcare Bhd gets a score of 9.71 in our stability test after the balance sheet, money statement study
Investing Malaysia –
Stock code of 0075 in Bursa Malaysia did not propose any dividend for the past few years
Investing Malaysia –
LYC is forecasted to made loss of 3.24 millions, with an adjusted market capitalization of 83.36 millions
REMUNERATION STUDY –
In Financial Year End 2019, the directors’ remuneration was 1.5 million. It was slightly high compared to average in listed companies, considering the employees’ remuneration of 4.1 million and auditor’s remuneration of 133 thousands